Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Laryngeal Neoplasms 2Head and Neck Neoplasms 1Disease 1

Interventions

Cisplatin 35Radiotherapy 21Magnetic Resonance Spectroscopy 19Cetuximab 17Specimen Handling 15pembrolizumab 13Carboplatin 13Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 121,2-diaminocyclohexaneplatinum II citrate 10Radiation 9Platinum 9Surgical Procedures, Operative 8Paclitaxel 8Drug Therapy 7Biopsy 7Taxes 5Surveys and Questionnaires 5toripalimab 4X-Rays 4Standard of Care 4Fluorodeoxyglucose F18 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Nutritional Status 3Laser Therapy 3Interviews as Topic 3Immunohistochemistry 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Laryngoscopy × Clear all
NCT01700647 2017-09-12

Breath Testing in Early and Late Larynx Cancer

Royal Brisbane and Women's Hospital

Completed
30 enrolled
Head & Neck

Disease, Laryngeal Neoplasms

NCT01073683 2010-03-05

Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer

Rabin Medical Center

Phase 2 Unknown
100 enrolled
Head & Neck

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡